“Promising” Treatment Trial Gives New Hope for the Deadliest Cancer


A team of researchers based in London have come with a new, revolutionary way of treating the deadliest and the most common cancer – pancreatic cancer. The all-new advanced treatment, as per the researchers, appears “very promising.”

A team of scientists at the Barts Cancer Institute & King’s College in London has seemingly cured mice having pancreatic cancer by providing them immunotherapy that makes use of the white blood cells for attacking the cancer tumors.

This approach of the trial appears similar to the one that is being successfully tested on children having leukemia. Around 10,000 individuals in the United Kingdom get diagnosed with pancreatic cancer every year. Out of them, only about 12 percent of the patients are able to survive for over 12 months.

Pancreatic cancer gets spotted only once after it has spread significantly. However, it can be cured through surgery during the early stages. Through the given research, the team of scientists claims that they have possibly achieved what seemingly cures pancreatic cancer in the animal models. The signs look positive in the case of the humans as well.

The treatment process involves the harvesting of the white blood cells and engineering them in a manner such that they multiply – before re-infusing them into the body. During the same time, a virus is altered for causing the cancer cells to transmit signals that help in identifying them to the given immunotherapy treatment. The news of the treatment appears immensely promising.

The given treatment is under discussion for the license by NHS for treating leukemia in children. The researchers are looking into the aspect of long-term survival of the children who might otherwise die.